Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Liver transplantation1521 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03454 | 33994708 | J Clin Exp Hepatol | Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation. | 2021 | Details |
| A03465 | 33992031 | Semin Liver Dis | Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms. | 2021 | Details |
| A03482 | 33987427 | Ann Transl Med | Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention. | 2021 | Details |
| A03483 | 33987425 | Ann Transl Med | Diagnostic management of nonalcoholic fatty liver disease: a transformational period in the development of diagnostic and predictive tools-a narrative review. | 2021 | Details |
| A03486 | 33987313 | Ann Transl Med | Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany. | 2021 | Details |
| A03498 | 33982400 | Liver Int | Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). | 2021 | Details |
| A03504 | 33978575 | Clin Liver Dis | The Changing Liver Transplant Recipient: From Hepatitis C to Nonalcoholic Steatohepatitis and Alcohol. | 2021 | Details |
| A03505 | 33978572 | Clin Liver Dis | Obesity Management of Liver Transplant Waitlist Candidates and Recipients. | 2020 | Details |
| A03509 | 33977096 | Can J Gastroenterol Hepatol | NAFLD and Infection, a Nuanced Relationship. | 2021 | Details |
| A03514 | 33974812 | Annu Rev Biomed Eng | Cell and Tissue Therapy for the Treatment of Chronic Liver Disease. | 2021 | Details |
| A03581 | 33946154 | Microorganisms | High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities. | 2021 | Details |
| A03692 | 33901295 | Hepatology | Functional Characterization of Organoids Derived From Irreversibly Damaged Liver of Patients With NASH. | 2021 | Details |
| A03761 | 33872099 | Scand J Gastroenterol | Etiologies and outcomes of cirrhosis in a large contemporary cohort. | 2021 | Details |
| A03796 | 33861449 | Adv Exp Med Biol | Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A03821 | 33857017 | Cancer Epidemiol Biomarkers Prev | Modest Impact of Liver Transplantation on Hepatocellular Carcinoma Mortality in the United States, Findings from The Transplant Cancer Match (TCM) Study. | 2021 | Details |
| A03823 | 33856246 | Expert Opin Emerg Drugs | Emerging synthetic drugs for the treatment of liver cirrhosis. | 2021 | Details |
| A03828 | 33855952 | Acta Medica (Hradec Kralove) | The Connection between MicroRNAs from Visceral Adipose Tissue and Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A03830 | 33855376 | Minerva Surg | NAFLD: a multi-faceted morbid spectrum with uncertain diagnosis and complicated management. | 2021 | Details |
| A03874 | 33837670 | Liver Transpl | Atherogenic Dyslipidemia After Liver Transplantation: Mechanisms and Clinical Implications. | 2021 | Details |
| A03877 | 33834737 | Am J Gastroenterol | Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites. | 2021 | Details |
| A03878 | 33834607 | Liver Transpl | Reduction of Visceral Adiposity as a Predictor for Resolution of Nonalcoholic Fatty Liver in Potential Living Liver Donors. | 2021 | Details |
| A03921 | 33816145 | World J Transplant | Noninvasive markers of liver steatosis and fibrosis after liver transplantation - Where do we stand? | 2021 | Details |
| A03972 | 33805795 | Nutrients | The Role of Resveratrol in Liver Disease: A Comprehensive Review from In Vitro to Clinical Trials. | 2021 | Details |
| A04036 | 33780554 | Transpl Int | Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis. | 2021 | Details |
| A04039 | 33780129 | Am J Transplant | Sleeve gastrectomy prior to liver transplantation is superior to medical weight loss in reducing posttransplant metabolic complications. | 2021 | Details |
| A04049 | 33776490 | J Exp Pharmacol | Experimental and Investigational Targeted Therapies for the Management of Fibrosis in NASH: An Update. | 2021 | Details |
| A04107 | 33755196 | Eur J Clin Invest | Pattern of macrovascular invasion in hepatocellular carcinoma. | 2021 | Details |
| A04129 | 33746450 | J Clin Exp Hepatol | Long-term Management of the Adult Liver Transplantation Recipients. | 2020 | Details |
| A04219 | 33709606 | J Gastroenterol Hepatol | Artificial intelligence in precision medicine in hepatology. | 2021 | Details |
| A04270 | 33681091 | Can J Gastroenterol Hepatol | Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular Carcinoma. | 2021 | Details |
| A04274 | 33680375 | Caspian J Intern Med | Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges. | 2020 | Details |
| A04280 | 33679051 | J Clin Exp Hepatol | Successful Outcome of Bariatric Surgery in Living Donor Liver Transplant Recipients With Multidisciplinary Approach: A Preliminary Experience. | 2020 | Details |
| A04289 | 33675775 | Biochem Pharmacol | Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model. | 2021 | Details |
| A04393 | 33636655 | Clin Res Hepatol Gastroenterol | Prevalence and clinical characteristics of alpha-1 antitrypsin deficiency in liver explants in a Mexican cohort. | 2021 | Details |
| A04411 | 33628759 | Can J Gastroenterol Hepatol | Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements. | 2021 | Details |
| A04456 | 33609303 | Hepatology | Microbiota-Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling. | 2021 | Details |
| A04463 | 33605666 | J Pediatr Gastroenterol Nutr | Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study. | 2021 | Details |
| A04471 | 33603899 | Maedica (Bucur) | Triple Antioxidant Therapy, an Alternative for Patients with Chronic Liver Disease - A Prospective Multicenter Interventional Study. | 2020 | Details |
| A04473 | 33603714 | Front Endocrinol (Lausanne) | Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery. | 2021 | Details |
| A04514 | 33592199 | Life Sci | Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. | 2021 | Details |
| A04567 | 33578449 | Biotechnol Appl Biochem | An insight into the role of telmisartan as PPAR-γ/α dual activator in the management of nonalcoholic fatty liver disease. | 2021 | Details |
| A04573 | 33576035 | Hepatology | Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP-Activated Protein Kinase Signaling Pathway. | 2021 | Details |
| A04574 | 33575290 | Hepatobiliary Surg Nutr | Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians. | 2021 | Details |
| A04596 | 33569476 | Ann Transl Med | A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases. | 2021 | Details |
| A04637 | 33555168 | Clin Transl Gastroenterol | Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation. | 2021 | Details |
| A04678 | 33544906 | Hepatology | De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations. | 2021 | Details |
| A04767 | 33511336 | JHEP Rep | Sex disparities in waitlisting and liver transplant for acute liver failure. | 2020 | Details |
| A04881 | 33468357 | Ultrasound Med Biol | Non-invasive Assessment of Liver Fat in ob/ob Mice Using Ultrasound-Induced Thermal Strain Imaging and Its Correlation with Hepatic Triglyceride Content. | 2021 | Details |
| A04918 | 33449917 | Endocr Connect | Pathophysiology of NASH in endocrine diseases. | 2021 | Details |
| A04942 | 33442446 | World J Hepatol | Metabolic associated fatty liver disease: Addressing a new era in liver transplantation. | 2020 | Details |
| A04956 | 33437903 | Hepatol Commun | The Natural History of NAFLD, a Community-Based Study at a Large Health Care Delivery System in the United States. | 2020 | Details |
| A04985 | 33425804 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship. | 2020 | Details |
| A05016 | 33409407 | Transl Gastroenterol Hepatol | Metabolic syndrome following liver transplantation in nonalcoholic steatohepatitis. | 2021 | Details |
| A05038 | 33398223 | J Clin Exp Hepatol | Effect of COVID-19 on Pre-existing Liver disease: What Hepatologist Should Know? | 2020 | Details |
| A05055 | 33392221 | Front Med (Lausanne) | Pre-transplant Sarcopenic Obesity Worsens the Survival After Liver Transplantation: A Meta-Analysis and a Systematic Review. | 2020 | Details |
| A05094 | 33378966 | Biomed Pharmacother | Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. | 2020 | Details |
| A05106 | 33374435 | J Clin Med | In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal. | 2020 | Details |
| A05161 | 33348908 | Int J Mol Sci | Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research. | 2020 | Details |
| A05256 | 33321020 | Acta Gastroenterol Belg | Proteins involved in lipid metabolism as possible biomarkers or predisposing factors for non-alcoholic fatty liver disease. | 2020 | Details |
| A05307 | 33307021 | Gastroenterology | AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. | 2020 | Details |
| A05344 | 33293992 | Evid Based Complement Alternat Med | Effect of Sheng-Jiang Powder on Gut Microbiota in High-Fat Diet-Induced NAFLD. | 2020 | Details |
| A05350 | 33290237 | Diagn Interv Radiol | MRI quantification techniques in fatty liver: the diagnostic performance of hepatic T1, T2, and stiffness measurements in relation to the proton density fat fraction. | 2021 | Details |
| A05416 | 33268331 | Biol Open | iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery. | 2020 | Details |
| A05433 | 33259137 | Liver Transpl | Histidine-Rich Glycoprotein Alleviates Liver Ischemia/Reperfusion Injury in Mice With Nonalcoholic Steatohepatitis. | 2021 | Details |
| A05435 | 33257853 | Nat Biomed Eng | A portable single-sided magnetic-resonance sensor for the grading of liver steatosis and fibrosis. | 2020 | Details |
| A05446 | 33253736 | Int J Cardiol | Sudden cardiac death following liver transplantation: Incidence, trends and risk predictors. | 2020 | Details |
| A05452 | 33251981 | Acta Chir Belg | Combined liver transplantation and off-pump coronary artery bypass grafting: a report of two cases. | 2020 | Details |
| A05506 | 33225408 | Obes Surg | Are We Ready for Bariatric Surgery in a Liver Transplant Program? A Meta-Analysis. | 2020 | Details |
| A05530 | 33217178 | Liver Transpl | Nonalcoholic Fatty Liver Disease and Diabetes Mellitus Are Associated With Post-Transjugular Intrahepatic Portosystemic Shunt Renal Dysfunction: An Advancing Liver Therapeutic Approaches Group Study. | 2021 | Details |
| A05583 | 33200011 | World J Hepatol | Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know! | 2020 | Details |
| A05592 | 33197060 | Magn Reson Med | Evaluation of hepatic steatosis before liver transplantation in ex vivo by volumetric quantitative PDFF-MRI. | 2020 | Details |
| A05676 | 33163950 | JHEP Rep | NAFLD and liver transplantation: Disease burden, current management and future challenges. | 2020 | Details |
| A05703 | 33149804 | Oxid Med Cell Longev | Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A05747 | 33134485 | Transplant Direct | Effect of Nonalcoholic Fatty Liver Disease and Metabolic Risk Factors on Waitlist Outcomes in Patients With Hepatocellular Carcinoma. | 2020 | Details |
| A05753 | 33132631 | World J Gastroenterol | Role of betaine in liver disease-worth revisiting or has the die been cast? | 2020 | Details |
| A05926 | 33073046 | Transl Gastroenterol Hepatol | Approach to prevention of non-alcoholic fatty liver disease after liver transplantation. | 2020 | Details |
| A05941 | 33069882 | Clin Gastroenterol Hepatol | Expert Panel Review on Nonalcoholic Fatty Liver Disease in Persons With Human Immunodeficiency Virus. | 2020 | Details |
| A05993 | 33047893 | Liver Transpl | Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium. | 2020 | Details |
| A06039 | 33031970 | Ann Hepatol | Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease. | 2020 | Details |
| A06073 | 33016540 | Aliment Pharmacol Ther | Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06128 | 32995320 | World J Transplant | Liver transplantation and aging. | 2020 | Details |
| A06203 | 32970896 | Clin Transplant | Association between obesity after liver transplantation and steatosis, inflammation, and fibrosis of the graft. | 2020 | Details |
| A06251 | 32952340 | World J Gastroenterol | Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice. | 2020 | Details |
| A06269 | 32946502 | PLoS One | Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019. | 2020 | Details |
| A06344 | 32921636 | Gut Liver | Recent Epidemiology of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A06362 | 32916011 | Liver Transpl | Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis. | 2020 | Details |
| A06402 | 32892401 | Scand J Immunol | Macrophages and scavenger receptors in obesity-associated non-alcoholic liver fatty disease (NAFLD). | 2020 | Details |
| A06537 | 32833053 | Langenbecks Arch Surg | Mechanisms of nonalcoholic fatty liver disease and implications for surgery. | 2020 | Details |
| A06543 | 32832402 | J Clin Transl Hepatol | NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United States. | 2020 | Details |
| A06560 | 32824744 | Int J Mol Sci | Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury. | 2020 | Details |
| A06568 | 32823659 | Int J Mol Sci | Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH. | 2020 | Details |
| A06582 | 32821068 | World J Gastroenterol | Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge. | 2020 | Details |
| A06590 | 32816619 | Gut Microbes | Modifying macronutrients is superior to microbiome transplantation in treating nonalcoholic fatty liver disease. | 2020 | Details |
| A06593 | 32815873 | J Clin Gastroenterol | Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases. | 2021 | Details |
| A06673 | 32785100 | Diagnostics (Basel) | Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06701 | 32775971 | EClinicalMedicine | Hospitalization costs and risk of mortality in adults with nonalcoholic steatohepatitis: Analysis of a French national hospital database. | 2020 | Details |
| A06786 | 32746645 | Expert Rev Gastroenterol Hepatol | Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma. | 2020 | Details |
| A06828 | 32732616 | Transplantation | Association of α 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation. | 2021 | Details |
| A06835 | 32730664 | Liver Int | Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood-based fibrosis markers in patients with chronic liver disease. | 2020 | Details |
| A06838 | 32728634 | Clin Exp Hepatol | Left ventricular diastolic dysfunction in liver transplantation: a stronger association with non-alcoholic steatohepatitis. | 2020 | Details |